Under proposed updates from NICE, more cases of ovarian cancer could be identified at an earlier stage by moving away from a uniform blood test threshold and introducing age-specific criteria. The guidance suggests tailoring the interpretation of CA125 test results to a woman’s age rather than applying a single cut-off for everyone. Ovarian cancer affects approximately one in fifty women…
Ben KempJanuary 20, 2026